Autopsy report · NCT02680717

Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea

“Unable to obtain IRB approval at all sites”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

Medical College of Wisconsin

Sponsor type

University, hospital or other

Conditions

Scleroderma

Interventions

Clobetasol; Calcipotriene; Tacrolimus

Participants

0

Trials that died the same way

• Transcranial Infrared Laser Stimulation (TILS) of Prefrontal Cognition in Post-traumatic Stress Disorder (PTSD)
  “IRB approval terminated” (77% match in meaning)
• Coronary Artery Study in Pediatric Heart Transplantation
  “never approved by IRB” (76% match in meaning)
• Early Detection of Cardiac Toxicity in Childhood Cancer Survivors
  “IRB approval expired” (76% match in meaning)
• Effect of Vascular Endothelial Growth Factor Blockers on Aqueous Humor Dynamics
  “Limited resources; IRB approval was not maintained” (75% match in meaning)
• Impact of Cardiac Resynchronization Therapy on Right Ventricular Function in Left Ventricular Assist Device Patients
  “IRB Approval withdrawn” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.